As Indian stock markets surge with Nifty50 approaching 26,000, experts reveal the profound connection between financial stability and mental wellbeing, offering insights into managing investment-related stress.
Modern parenting presents unique health challenges with increased screen time and packed schedules. Discover four evidence-based strategies to build lasting health foundations for your child's physical and mental development.
Omega Healthcare demonstrates excellence in AI-driven healthcare solutions, earning five A+ grades and a remarkable 97.8 performance score in the latest KLAS First Look Report, setting new industry standards.
America's national health interoperability network TEFCA has exchanged nearly 500 million health records, marking a transformative milestone in healthcare data sharing and patient care coordination.
Groundbreaking research reveals obesity contributes to one in ten deaths from infectious diseases worldwide, highlighting an urgent public health crisis that demands immediate attention and intervention strategies.
Arecor Therapeutics announces strategic plans to advance its innovative insulin therapy into Phase II clinical trials by 2026, following successful 2025 developments that position the company at the forefront of diabetes treatment innovation.
Groundbreaking research from Liverpool reveals that metformin, a common diabetes medication, may reduce age-related macular degeneration by 37%, offering new hope for preserving eyesight in aging populations.
Groundbreaking research reveals a 44-metabolite blood signature that predicts type 2 diabetes risk with unprecedented accuracy, potentially transforming preventive healthcare and early intervention strategies.
Groundbreaking research reveals obesity contributes to one in ten deaths from infectious diseases worldwide, highlighting an urgent public health crisis that demands immediate attention and intervention strategies.
Arecor Therapeutics announces strategic plans to advance its innovative insulin therapy into Phase II clinical trials by 2026, following successful 2025 developments that position the company at the forefront of diabetes treatment innovation.
Groundbreaking research from Liverpool reveals that metformin, a common diabetes medication, may reduce age-related macular degeneration by 37%, offering new hope for preserving eyesight in aging populations.
Groundbreaking research reveals a 44-metabolite blood signature that predicts type 2 diabetes risk with unprecedented accuracy, potentially transforming preventive healthcare and early intervention strategies.
Get the latest health news delivered to your inbox.
We respect your privacy. Unsubscribe at any time.
